Idelvion recombinant coagulation Factor IX regulatory update

FDA approved a BLA from CSL’s CSL Behring subsidiary for Idelvion recombinant coagulation Factor IX in adults or children with hemophilia B. CSL plans to launch Idelvion the week of March 21. The prod...